Cargando…
The development of mesenchymal stem cell therapy in the present, and the perspective of cell-free therapy in the future
Cirrhosis is a chronic condition that can lead to liver failure. Currently, the viable option for decreasing mortality is liver transplantation. However, transplant surgery is highly invasive. Therefore, cell-based therapy has been developed as an alternative. Based on promising findings from precli...
Autores principales: | Watanabe, Yusuke, Tsuchiya, Atsunori, Terai, Shuji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association for the Study of the Liver
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820202/ https://www.ncbi.nlm.nih.gov/pubmed/33317249 http://dx.doi.org/10.3350/cmh.2020.0194 |
Ejemplares similares
-
Mesenchymal stem cell therapies for liver cirrhosis: MSCs as “conducting cells” for improvement of liver fibrosis and regeneration
por: Tsuchiya, Atsunori, et al.
Publicado: (2019) -
Clinical trials using mesenchymal stem cells in liver diseases and inflammatory bowel diseases
por: Tsuchiya, Atsunori, et al.
Publicado: (2017) -
Transition of clinical and basic studies on liver cirrhosis treatment using cells to seek the best treatment
por: Terai, Shuji, et al.
Publicado: (2021) -
Diverse perspectives to address for the future treatment of heterogeneous hepatocellular carcinoma
por: Tsuchiya, Atsunori, et al.
Publicado: (2019) -
Combination therapy of Juzentaihoto and mesenchymal stem cells attenuates liver damage and regresses fibrosis in mice
por: Iwasawa, Takahiro, et al.
Publicado: (2021)